417 related articles for article (PubMed ID: 15102364)
1. The Guillain-Barré syndrome: a true case of molecular mimicry.
Ang CW; Jacobs BC; Laman JD
Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside mimicry and peripheral nerve disease.
Yuki N
Muscle Nerve; 2007 Jun; 35(6):691-711. PubMed ID: 17373701
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
Yuki N
Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
[TBL] [Abstract][Full Text] [Related]
6. [Guillain-Barre syndrome: etiology and pathogenesis].
Avila-Funes JA; Mariona-Montero VA; Melano-Carranza E
Rev Invest Clin; 2002; 54(4):357-63. PubMed ID: 12415961
[TBL] [Abstract][Full Text] [Related]
7. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
8. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of axonal Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
11. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
12. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
[TBL] [Abstract][Full Text] [Related]
13. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.
Moran AP; Prendergast MM
J Autoimmun; 2001 May; 16(3):241-56. PubMed ID: 11334489
[TBL] [Abstract][Full Text] [Related]
14. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides as targets for autoimmune injury to the nervous system.
Willison HJ
J Neurochem; 2007 Nov; 103 Suppl 1():143-9. PubMed ID: 17986149
[TBL] [Abstract][Full Text] [Related]
16. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases].
Korzeniowska-Kowal A; Witkowska D; Gamian A
Postepy Hig Med Dosw; 2001; 55(2):211-32. PubMed ID: 11468971
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
Ebrahim Soltani Z; Rahmani F; Rezaei N
Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome.
Kountouras J; Deretzi G; Grigoriadis N; Zavos C; Boziki M; Gavalas E; Katsinelos P; Tzilves D; Giouleme O; Lazaraki G
Lancet Neurol; 2008 Dec; 7(12):1080-1; author reply 1083-5. PubMed ID: 19007730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
